U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. Public Health Focus
  4. Warning Letters and Test Results for Cannabidiol-Related Products
  1. Public Health Focus

Warning Letters and Test Results for Cannabidiol-Related Products

 

Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products.

Firm State Purchase Website
Honest Globe, Inc. CA elixicure.com
BioLyte Laboratories, LLC MI N/A
Cannafy AZ cannafyl.com
Evolved Ayurvedic Discoveries Inc./BioCBDPlus CA biocbdplus.com
Back to Top